Posted on 02/10/2022 2:16:18 PM PST by SpeedyInTexas
A panel advising U.S. drug regulators said Eli Lilly and Co. and its Chinese partner should conduct more studies of a proposed new lung-cancer drug before approval, citing concerns about the medicine’s testing in China.
...
Harpreet Singh, an FDA division director, said FDA inspectors found that researchers conducting the study at two sites in China underreported adverse events in patients. The study “only offers uncertainty,” she said.
(Excerpt) Read more at wsj.com ...
The check didn’t clear.
Considering the intellectual and political corruption in China, it’s a no-brainer. Unfortunately, people in Washington often have no brains.
“We have a new cancer drug. It’s from China.”
“Is it effective?”
“Yes. Everyone we’ve given it to so far has gotten cancer.”
What Do They Know that We Don’t?… China Has Not Administered a Single mRNA Vaccine to Any of Its 1.45 Billion Citizens
“Chinese Firm Buys Canada mRNA Vaccine Tech in $500 Million Deal”
They are trying to buy the technology. If they can’t steal it, they try to buy it.
Eh release it.
We can see the test trials information after 2070. What’s
the problem.
/s
(that’s what is known as a COVID-19 process)
(or as Nancy would say, we have to approve it before we can
tell you what’s wrong with it.)
I wouldn’t want to depend on any medicine coming from China — and a lot of them do.
biden probABLY wears Depends made in china.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.